Developed through deep relationships across the local and global ecosystem, the Deloitte Life Sciences Catalyst exists to solve the business challenges that keep life sciences leaders and innovators up at night.
The Deloitte Life Sciences Catalyst launched in Cambridge on Tuesday 22 September. The virtual event involved a panel of esteemed experts who explored the contribution of the life sciences sector to economic growth and a discussion of the support available for companies in this space.
Joining the panel discussion were; Sir Mene Pangalos, Executive VP of AstraZeneca; Harriet Fear MBE…
Research Triangle Park, NC, USA and Cambridge, UK, 22 September 2020 – Inivata, a leader in liquid biopsy, today announces the appointment of Peter Collins as Chief Business Officer, effective immediately. Peter will be responsible for leading all business development, partnering and commercial activities.
Peter brings over 30 years of experience working in the biopharmaceutical sector, having held senior leadership positions in several molecular diagnostics companies, most recently at Guardant Health. Peter has also served as Chief Business Officer of Yourgene Health, where he led all…
We all hope that a COVID-19 vaccine is on the horizon - but the global cold chain must be prepared to distribute these vaccines around the world.
This is an unprecedented task, with a large number of transfer points across vast geographic regions. Vaccines may have to travel from manufacturing facilities to storage and distribution centres, and then onwards to healthcare facilities for local administration or cold storage.
Determining the temperature requirements of potential COVID-19 vaccines
As it stands, there is not a consensus within the scientific community regarding the potential…
Benefits of the programme include access to the Babraham Research Campus bio-incubator facilities, an extended programme of mentoring and support and £10k undiluted funding
Babraham 21st September 2020: The Babraham Research Campus’ third cohort of Accelerate@Babraham life science start-ups came together today for the first day of the 2020/21 programme.Having received multiple, high-calibre applications via the Accelerate@Babraham Start-Up Competition, selection of the winning cohort took place in July, with eight finalists shortlisted to present remotely via Zoom to…
Cambridge, UK., 21 September 2020: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that its abstract titled ‘Phase I study investigating the PD, PK and safety of AT247 in comparison to insulin aspart, NovoRapid®, and fast insulin aspart, Fiasp®, has been selected for oral presentation at the upcoming European Association for the Study of Diabetes (EASD) virtual meeting which will be held from 21-25 September 2020. Abstract #55 is available online.
Dr Eva Svehlikova, Medical Director of the…
Growth continues at Discovery Park as new tenants arrive
Psyros Diagnostics & VisusNano join innovation community
Sandwich, Kent, September 21 2020 – The innovation community is continuing to evolve at Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies, as new tenants move in and others continue to develop. New entrants Psyros Diagnostics and VisusNano have both taken laboratory and office space at the Park.
Medtech company VisusNano’s new facilities will enable the rapid scale up of the company’s proprietary biodegradable intraocular…
StemFit® for Mesenchymal Stem Cells (MSC) is the latest addition to the StemFit® family of stem cell media. It is a chemically defined and human/animal origin free medium, optimized for the isolation and culture of MSCs from bone marrow (BM-MSC), umbilical cord (UC-MSC), and adipose (ADSC) under serum-free, human platelet lysate free conditions.The fully chemically defined formulation of StemFit® for MSC minimizes lot-to-lot variation and enables highly consistent and superior cell expansion compared to serum containing media. Containing no animal or human-derived components minimizes…
Pharmaceutical and biotech product development consultancy Boyds has recruited Kathryn Bartley as Senior Clinical Research Associate.
The appointment follows last year’s acquisition of Blue Duck Consultancy which fueled the expansion of Boyds’ in-house clinical and medical affairs services offering.
Kathryn has over 18 years’ experience in the industry, primarily in study and site management and monitoring. Her work has covered a variety of therapy areas across all trial phases within both the commercial and academic sectors.
Most recently, Kathryn spent six years working for GlaxoSmithKline…
Cambridge, UK, 08 September 2020: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced it has significantly enhanced its global business development capabilities, with additional resources now committed to support key regions in the USA, Europe and Japan.
Anca Haralambie has been appointed as Business Development Executive, representing Metrion in the UK and across Europe. Anca has broad experience of supporting clients in the global drug discovery sector, with particular expertise in translational research and induced…
9 September 2020, Oxfordshire, UK/Boston, US – Life Science Newswire – Precision medicine company PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment demonstrates the company’s focus on developing the US market and its commercial profile within the healthcare and precision medicine fields. Simon brings with him a wealth of experience, having spent more than 20 years leading product and business strategy and teams for innovative informatics businesses in the healthcare and life science ecosystems.Most recently, Simon was Director of…